Another model based on Aβ1-42 and T-tau was developed that could accurately discriminate AD from controls by means of a discrimination line, which has been validated in clinical practice [32] and in autopsy-confirmed patients with sensitivity levels of 100% and specificity of 91% [26]. Here, MAPT is linked to Alzheimer disease.